{"id":"W4400797335","doi":"10.1007/s00277-024-05851-4","title":"Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia","year":2024,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Medicine; Tolerability; Dosing; Myeloid leukemia; Adverse effect; Tyrosine-kinase inhibitor; Dasatinib; Oncology; Clinical trial; Internal medicine; Pharmacology; Intensive care medicine; Imatinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002558955,0.0003921163,0.002142473,0.0002704769,0.00003279134,0.00000819909,0.0001074375,0.0002977556,0.00005656253],"category_scores_gemma":[0.00009529808,0.0002176372,0.0003858819,0.0003463314,0.0002032887,0.0000372358,0.00006146079,0.000341054,0.00002364038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002952473,"about_ca_system_score_gemma":0.001830983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002795932,"about_ca_topic_score_gemma":0.00003085823,"domain_scores_codex":[0.9976709,0.0001557868,0.001081041,0.0004443467,0.0002744308,0.0003734385],"domain_scores_gemma":[0.9979057,0.0007438342,0.0005333825,0.0006200077,0.0001417011,0.00005541081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007347108,0.003689125,0.000827131,0.548539,0.0200647,0.004544403,0.0006124565,0.000003431401,6.961855e-7,0.1418999,0.08560991,0.1934746],"study_design_scores_gemma":[0.007468197,0.004212111,0.0002936852,0.06224323,0.01813748,0.003064947,0.0001655519,0.00003026006,0.0001523102,0.0006874699,0.9029794,0.000565315],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008311546,0.9921621,0.00001199311,0.0008632761,0.00006318528,0.004371588,0.0001690314,0.00002311638,0.001504559],"genre_scores_gemma":[0.006447982,0.9905673,0.0009861115,0.000128949,0.00003358717,0.0009752426,0.0006477169,0.00005997786,0.0001531946],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8173695,"threshold_uncertainty_score":0.8874987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1228216331662809,"score_gpt":0.4212472540472785,"score_spread":0.2984256208809976,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}